
This episode discusses physiology-guided sepsis resuscitation and the implications of the ANDROMEDA-SHOCK 2 trial with guest Jaclyn Bond.
The science is finally catching up to what clinicians have long known: more fluids aren't always the answer to septic shock. In this episode, host Sarah Lorenzini and Jaclyn Bond MSN-LM, MBA-HM explain what the ANDROMEDA-SHOCK 2 trial reveals about physiology-guided sepsis resuscitation and why fixed-volume fluid strategies can lead to avoidable harm. They break down how dynamic fluid responsiveness testing helps teams stop guessing, and how tools like FloPatch support real-time assessment of carotid flow time and stroke volume. You'll leave with a clearer idea of when to give fluids, when to stop, and how to justify the decision. Topics discussed in this episode: The purpose and key findings of the ANDROMEDA-SHOCK 2 study Why dynamic measures of fluid responsiveness matter more than static vitals What recent meta-analysis data shows about physiology-guided fluid strategies Carotid flow time: what it is, how it’s measured, and how it guides decisions Hemodynamic assessment and bedside limitations How FloPatch supports real-time assessment so you can make individualized fluid decisions SEP-1 2026 guideline updates and why it’s better for patients How to apply these principles to…
Explore listener stats, chart rankings, contacts and more on the Rapid Response RN podcast page.